BioCentury
ARTICLE | Clinical News

BiodivYsio stent: Marketed

May 10, 1999 7:00 AM UTC

In a 426-patient study comparing BII’s BiodivYsio stents to historical controls, patients treated with the stents had an 11 percent rate of major adverse cardiac events compared to 16 percent historically, a 6.2 percent rate of target vessel revascularization (TVR) compared to 10-11 percent historically, and a 17 percent rate of angiographic restenosis compared to 17-25 percent historically. The rate of angiographic restenosis was 16 percent in small vessels, where the consensus estimate of the historical rate is 20-40 percent. ...